Cambridge Investment Research Advisors, Inc. Charles River Laboratories International, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,554 shares of CRL stock, worth $303,465. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,554
Previous 1,926
19.31%
Holding current value
$303,465
Previous $290,000
18.62%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CRL
# of Institutions
630Shares Held
52.5MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.13 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$994 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$736 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$425 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$363 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.93B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...